Related references
Note: Only part of the references are listed.Analysis of antibiotic usage for viral community-acquired pneumonia in adults
Rongmeng Jiang et al.
FRONTIERS OF MEDICINE (2021)
Updated systematic review and meta-analysis of the predictive value of serum biomarkers in the assessment and management of fever during neutropenia in children with cancer
Tasnim Arif et al.
PEDIATRIC BLOOD & CANCER (2019)
Role of C-reactive protein and procalcitonin in discriminating between infectious fever and tumor fever in non-neutropenic lung cancer patients
ZhifangY Zhao et al.
MEDICINE (2018)
Procalcitonin-Guided Antibiotic Therapy Reduces Antibiotic Use for Lower Respiratory Tract Infections in a United States Medical Center: Results of a Clinical Trial
Jennifer Townsend et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
Utility of blood procalcitonin concentration in the management of cancer patients with infections
Bonita Durnas et al.
ONCOTARGETS AND THERAPY (2016)
Procalcitonin as diagnostic marker of infection in solid tumors patients with fever
B. Vincenzi et al.
SCIENTIFIC REPORTS (2016)
Value of lipopolysaccharide binding protein as diagnostic marker of infection in adult cancer patients with febrile neutropenia: comparison with C-reactive protein, procalcitonin, and interleukin 6
Luis Garcia de Guadiana-Romualdo et al.
SUPPORTIVE CARE IN CANCER (2015)
Identification of Predictive Early Biomarkers for Sterile-SIRS after Cardiovascular Surgery
Sandra Stoppelkamp et al.
PLOS ONE (2015)
Clinical Value of Procalcitonin for Patients With Suspected Bloodstream Infection
Takuya Hattori et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
The Utility of Proadrenomedullin and Procalcitonin in Comparison to C-Reactive Protein as Predictors of Sepsis and Bloodstream Infections in Critically III Patients With Cancer
Labib Debiane et al.
CRITICAL CARE MEDICINE (2014)
Clinical Utility of Procalcitonin as a Marker of Sepsis: A Potential Predictor of Causative Pathogens
Atsuko Nakajima et al.
INTERNAL MEDICINE (2014)
Procalcitonin beyond the acute phase: novel biomediator properties?
Carolina Panico et al.
BMC MEDICINE (2013)
Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance
F. Dusemund et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2013)
Prediction of outcome in cancer patients with febrile neutropenia:: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1β, -6, -8 and -10
A. Uys et al.
EUROPEAN JOURNAL OF CANCER CARE (2007)
Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulase-negative staphylococci
P. Schuetz et al.
INFECTION (2007)
Causes of fever and value of C-reactive protein and procalcitonin in differentiating infections from paraneoplastic fever.
N Penel et al.
SUPPORTIVE CARE IN CANCER (2004)
Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia
A Jimeno et al.
CANCER (2004)
Share Paper
